JPMorgan cut its recommendation on the stock to “Underweight” from “Neutral” and withdrew its price target.Finance, news, Silvergate Bank, JPMorganRead More

You might also be interested in reading NVO DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Novo Nordisk A/S Investors with Losses in Excess of $100K to Secure Counsel Before Important September 30 Deadline in Securities Class….